Transaction #28669 · Form 4 · 0001679166-26-000013
Elanco Animal Health Inc · Stock award · Deferred Stock Units
Elanco Animal Health Inc · Transacted September 30, 2026 · Filed October 1, 2026
What does this filing report?
An SEC Form 4 filing for Elanco Animal Health Inc records a stock award involving Deferred Stock Units on September 30, 2026. The reported quantity was 642.0277. The filing date is October 1, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Elanco Animal Health Inc
- Company CIK
- 0001739104
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 642.0277
- Reported price
- 22.39 · See footnotes
- Reference value
- 14,375.000203
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 10,721.5916
- Ownership description
- Not reported
- SEC acceptance time
- Oct 1, 2026, 4:04 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Anand Kapila K ↗
Director
CIK 0001679166
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 642.0277
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
- F2
- The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
- F3
- The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.